Page last updated: 2024-12-06

imipramine n-oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

imipramine N-oxide: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65589
CHEMBL ID1614644
CHEBI ID135256
SCHEMBL ID49238
MeSH IDM0043751

Synonyms (46)

Synonym
imipramine n-oxide
nsc 169424
D07334
imipraminoxide (inn)
6829-98-7
imipramine oxide
CHEBI:135256
imipraminoxide
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-n,n-dimethylpropan-1-amine oxide
5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n-dimethyl-, n-oxide
5-(3-(dimethylamino)propyl)-10,11-dihydro-5h-dibenz(b,f)azepine 5-oxide
imipraminoxide [inn]
8mks280xjw ,
imipraminoxido
imipraminoxido [inn-spanish]
elepsin
10,11-dihydro-n,n-dimethyl-5h-dibenz(b,f)azepine-5-propanamine n-oxide
imipraminoxidum
5h-dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-, n-oxide
unii-8mks280xjw
5-(3-(dimethylamino)propyl)-10,11-dihydro-5h-dibenz(b,f)azepine n-oxide
imipraminoxidum [inn-latin]
einecs 229-907-1
CHEMBL1614644
FT-0630353
SCHEMBL49238
smr001550525
MLS006010770
imipraminoxide, imipraminoxide (imipramine n-oxide)
imipramine n-oxide [mi]
imipraminoxide [who-dd]
5h-dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-n,n-dimethyl-, n-oxide
5-[3-(dimethylamino)propyl]-10,11-dihydro-5h-dibenz[b,f]azepine n-oxide
10,11-dihydro-5-(3-(dimethylamino)propyl)-5h-dibenz[b,f]azepine n-oxide
QZIQORUGXBPDSU-UHFFFAOYSA-N
5-[3-(dimethylamino)propyl]-10,11-dihydro-5h-dibenz[b,f]azepine 5-oxide
DTXSID40218445
AKOS030254360
imipramine n-oxide; 5h-dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-n,n-dimethyl-, n-oxide; 5h-dibenz[b,f]azepine, 5-[3-(dimethylamino)propyl]-10,11-dihydro-, n-oxide (7ci,8ci); 5-[3-(dimethylamino)propyl]-10,11-dihydro-5h-dibenz[b,f]azepine 5-oxide; i
3-(10,11-dihydro-5h-dibenzo[b,f]azepin-5-yl)-n,n-dimethylpropan-1-amine oxide
DB13782
Q15409428
5h-dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-n,n-dimethyl-,n-oxide
MS-24252
HY-142122
CS-0377805

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" pharmacokinetic data on 670 drugs representing, to our knowledge, the largest publicly available set of human clinical pharmacokinetic data."( Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Lombardo, F; Obach, RS; Waters, NJ, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dibenzooxazepineAn organic heterotricyclic compound consisting of two benzene rings fused to a seven-membered ring containing one oxygen and one nitrogen atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (45.00)18.7374
1990's7 (35.00)18.2507
2000's3 (15.00)29.6817
2010's1 (5.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.05 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.15 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]